As of 2025-07-07, the Relative Valuation of Rubius Therapeutics Inc (RUBY) is (86.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Rubius Therapeutics Inc based on Relative Valuation is -104179.0%.
The range of the Relative Valuation is (72.64) - (85.55) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.4x - 29.6x | 27.0x |
| Forward P/E multiples | 25.1x - 41.6x | 32.7x |
| Fair Price | (72.64) - (85.55) | (86.39) |
| Upside | -87617.0% - -103167.9% | -104179.0% |
| Date | P/E |